Continued organic growth and stable margin in the third quarter - a quarter that is normally somewhat weaker seasonally. The work on profitability improvements is progressing according to plan.
A European partner in Life Science
Our vision is to improve people's lives by being a leading, value-adding partner in Life Science
INTERIM REPORT Q3 2024
Share price
Press Releases
Report
Calendar
-
![1 Fredrik Dalborg Q3 2024]()
-
AddLife acquires BonsaiLab
To BonsailabBonsaiLab is a leading Spanish distributor in the field of cell and molecular biology. The company’s offering includes cutting-edge technology products, analytical solutions, and services for genomics laboratories in Spain and Portugal, including products for next generation sequencing, genomic analysis as well as sample preparation. The company, with current revenues of EUR 8 m, has 13 employees and will be included in AddLife’s business area Labtech.
![Adobestock 670238669]()
-
Improving people´s lives
Watch VideoAddLife's vision is to enhance people's lives by being a leading, value-adding partner in Life Science. Our dedicated employees across 85 subsidiaries in Europe support customers with a range of services. These include providing products for the increasing the number of surgeries, improving the ability of the elderly or disabled to live at home, enabling healthcare diagnostics, and facilitating life science research.
![Improving Peoples Lives Youtube]()
Our business areas
MEDTECH
In the Medtech business area, the subsidiaries offer products and services in medical technology, as well as assistive equipment and digital solutions for use in home care. Medtech has two business units - Hospital and Homecare. The Medtech offering mainly focuses on publicly funded healthcare, home care and social care in Europe.
Read more
LABTECH
The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. The business area consists of two business units: Biomedical and Research and Diagnostics. The most important customer groups are hospital laboratories, academic research and pharmaceutical companies in Europe.
Read moreJoin the AddLife group
Do you have a Life Science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary, you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.
News from our subsidiaries
05 November 2024
Hepro designs and manufactures high-quality products
At AddLife AB, our home care companies offer products and services that improve daily independence.
Hepro
29 October 2024 | Triolab AS
We want to improve our way of working with sustainability
Sustainability is a central part of our vision to improve people's lives. Our commitment to improving people's lives is not just our slogan; it is an integral part of our daily operations and a cornerstone of our long-term strategy.
21 October 2024 | Triolab OY
Environmental certificate
Triolab Oy has been awarded the ISO 14001 environmental certificate. What is it and how does it affect Triolab’s operations?
20 October 2024 | AddLife
AddLife visit to the Ukraine
This week AddLife CEO Fredrik Dalborg and Head of Business Development Christian Karlsson together with the Swedish Minister of Health Acko Ankarberg Johansson, the Director General of the Swedish National Board of Health and Welfare (Socialstyrelsen) Björn Eriksson, as well as representatives from Swedish and Finnish companies, authorities and academia took part in a very special visit to the Ukraine.
Sustainability for AddLife
Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in Life Science. AddLife´s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.
